SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to speculation of a potential short squeeze, fueled by its low float and recent breakout above the 200 SMA. The community is actively discussing potential price targets and comparing ARBB's setup to previous low-float runners like $SMX, anticipating a significant upward move. Bullish sentiment is high, with many traders closely watching key breakout levels.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to a mix of factors, including recent price declines and discussions around its potential as an AI infrastructure play. Community members are debating whether the stock is oversold or fairly valued, while also keeping an eye on potential catalysts and the broader AI sector. Comparisons to peers and discussions around upcoming earnings and potential deals are contributing to the heightened interest.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential cannabis rescheduling under the Trump administration, with community members discussing the possibility of a short squeeze and significant price gains. The enthusiasm is fueled by anticipation of eased regulations, tax benefits, and increased institutional investment in the cannabis sector. However, some caution against hype, pointing out previous false alarms and potential dilutions.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO is trending amid discussions around immigration policy and its potential impact on private prison operators. Community members are pointing to news events involving immigration and ICE activity, while differing opinions exist on the company's valuation and future prospects, with some anticipating a rise and others expressing skepticism.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending amid discussions of its AI & Autonomy Day, where the company highlighted its new in-house AI chip and self-driving capabilities, leading to increased confidence and analyst upgrades. The community is weighing the potential for a short squeeze and comparing Rivian's technology and approach to that of Tesla. Some investors express concerns about cash burn and the timeline for implementing new technologies.

Equinox Gold Corp. is a growth-focused mining company, which engages in the exploration of gold mining properties. It operates through the following segments: Greenstone, Mesquite, Castle Mountain, Los Filos, Aurizona, Fazenda, RDM, Santa Luz, and Corporate. The company was founded by Marc Pais on March 23, 2007, and is headquartered in Vancouver, Canada.

Equinox Gold Corp

Equinox Gold is trending following the announcement of the sale of its Brazil operations, a deal expected to bring in over $1 billion and allow the company to focus on North American growth. The community is speculating on how the funds will be used, with debt reduction and potential expansion of the Los Filos mine in Mexico being key talking points. Some investors are also pointing to rising gold prices as a potential tailwind for the company.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

KYTX is trending due to anticipation surrounding upcoming Phase 2 data release for its KYV-101 trial in Stiff Person Syndrome, with the community actively discussing potential catalysts and the company's valuation relative to its cash reserves. Some investors believe positive news could lead to a significant price increase, while others express concerns about recent price declines and potential dilution. The stock's potential as an acquisition target, especially by Gilead, is also being debated.

Fox Corp. engages in providing television production and broadcasting services. It also provides news under the brands FOX News Media, FOX Sports, FOX Entertainment and FOX Television Stations, and Tubi Media Group. It operates through the following segments: Cable Network Programming, Television, and Other and Corporate. The Cable Network Programming segment refers to the production and licensing of news and sports content distributed primarily through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies and online multi-channel video programming distributors. The Television segment focuses on the acquisition, marketing, and distribution of broadcast network programming. The Other and Corporate segment relates to the FOX Studio Lot, Credible Labs Inc, corporate overhead costs, and intracompany eliminations. The company was founded by Keith Rupert Murdoch on May 3, 2018, and is headquartered in New York, NY.

Fox Corporation - Ordinary Shares - Class B

Fox Corporation - Class B

FOX is trending due to community discussions about potential trading opportunities, particularly around upward momentum and overbought conditions as indicated by RSI. Some traders are using recent price action and moving averages to formulate entry and exit points, while others are discussing the company's legal settlements related to defamation lawsuits and potential political biases. Broader conversations touch upon the media landscape, comparisons with competitors like $WBD and $NMAX, and the impact of political events.

Dingocoin is an open source peer-to-peer digital currency.

Dingocoin

Dingocoin is gaining attention as traders discuss its breakout potential and momentum. The community is drawn to its relatively small supply, viewing it as an early-stage opportunity. Comparisons to other meme coins and forks of Doge, like BabyDoge, are circulating among investors.

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Immunome Inc

IMNM is trending due to upcoming Phase 3 RINGSIDE trial data for Varegacestat, anticipated to be released soon. The community is discussing the potential for a pop or sell-off based on the results, with some expressing nervousness around lack of prior data. Broader sentiment suggests potential based on a sizable TAM (Total Addressable Market).

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sera Prognostics (NASDAQ:SERA) CEO Zhenya Lindgardt Sells 4,155 Shares

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 4,155 shares of Sera Prognostics stock in a transaction on Wednesday, December 10th. The shares were sold at an...

Insider Selling: Sera Prognostics (NASDAQ:SERA) CEO Sells 4,155 Shares of Stock

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 4,155 shares of the company's stock in a transaction on Wednesday, December 10th. The stock was sold at an average...

Sera Prognostics (NASDAQ:SERA) CFO Sells $15,905.28 in Stock

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CFO Austin Aerts sold 5,232 shares of the firm's stock in a transaction dated Tuesday, December 9th. The stock was sold at an average price of...

Sera Prognostics (NASDAQ:SERA) CEO Sells $85,773.60 in Stock

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 28,215 shares of the business's stock in a transaction dated Tuesday, December 9th. The shares were sold at an average...

Sera Prognostics (NASDAQ:SERA) CFO Austin Aerts Sells 5,232 Shares

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CFO Austin Aerts sold 5,232 shares of the company's stock in a transaction on Tuesday, December 9th. The shares were sold at an average price of...

Sera Prognostics (NASDAQ:SERA) Shares Down 3.6% - What's Next?

Sera Prognostics (NASDAQ:SERA) Shares Down 3.6% - Here's Why...

Sera Prognostics (SERA) Upgraded to Buy: Here's Why

Sera Prognostics (SERA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Sera Announces Publication Acceptance for PRIME Study

Sera Announces Publication Acceptance for PRIME Study Sera Announces Publication Acceptance for PRIME Study PR Newswire SALT LAKE CITY, Nov. 24, 2025 The PRIME study, one of the largest studies on...

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of...

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Sera Prognostics (NASDAQ:SERA - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.16) earnings per share for the quarter, topping analysts' consensus estimates...

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

SERA
Sera Prognostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SERA News

SERASera Prognostics Inc